Controlled drug delivery vehicles for cancer treatment and their performance
Системы контролируемой доставки лекарственных препаратов для лечения рака и их эффективность
2018-03-14
SCID: 54.1/6phyakes
Discuss with AI
cancer treatmentchemotherapeutic agentscontrolled drug deliverydrug delivery vehiclesmultiple drug resistance
Figures from the paper
Abstract (AI)
Although conventional chemotherapy has been successful to some extent, the main drawbacks of chemotherapy are its poor bioavailability, high-dose requirements, adverse side effects, low therapeutic indices, development of multiple drug resistance, and non-specific targeting. The main aim in the development of drug delivery vehicles is to successfully address these delivery-related problems and carry drugs to the desired sites of therapeutic action while reducing adverse side effects. In this review, we will discuss the different types of materials used as delivery vehicles for chemotherapeutic agents and their structural characteristics that improve the therapeutic efficacy of their drugs and will describe recent scientific advances in the area of chemotherapy, emphasizing challenges in cancer treatments.
Key Findings
1
Controlled drug delivery vehicles are designed to transport chemotherapeutic agents to desired therapeutic sites while reducing adverse side effects.
2
Conventional chemotherapy is limited by poor bioavailability, high dosing requirements, adverse effects, low therapeutic indices, multidrug resistance, and nonspecific targeting.
3
Recent advances in controlled drug delivery for cancer treatment are discussed alongside persistent challenges in developing more effective chemotherapy strategies.
4
The review examines different materials used as chemotherapy delivery vehicles and how their structural characteristics can improve therapeutic efficacy.
Research Object
Controlled drug delivery vehicles for chemotherapeutic agents
Research Subject
the materials and structural characteristics of drug delivery vehicles that improve therapeutic efficacy while reducing adverse effects and addressing delivery limitations
Publication Details
Publication Date
2018-03-14
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest